Keyphrases
Cardiogenic Shock
100%
Acute Coronary Syndrome
60%
ST-elevation Myocardial Infarction (STEMI)
30%
Takotsubo Syndrome
26%
90-day Mortality
25%
Elderly Patients
16%
In-hospital Mortality
15%
High-sensitivity Cardiac Troponin
14%
Mortality Prediction
14%
Growth Differentiation factor-15 (GDF-15)
14%
Risk Stratification
12%
Risk Score
12%
Emergency Department
12%
Frailty
12%
European Society of Cardiology
12%
Pulmonary Artery Catheter
11%
Prognostic Impact
11%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
10%
Predictive Value
10%
Clinical Value
10%
Soluble Suppression of Tumorigenicity 2 (sST2)
10%
Lipid Management
10%
Acute Decompensated Heart Failure
10%
EAPCI
10%
Hazard Ratio
9%
Clinical Variables
9%
All-cause Mortality
9%
High Sensitivity
9%
Area under the Curve
9%
Confidence Interval
9%
ST-segment Elevation
9%
Shock Patient
8%
Prognostic Value
8%
Circulating Levels
8%
Non-survivors
8%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
8%
Etiology
8%
Acute Heart Failure
7%
Angiography
7%
Reclassification
7%
Heart Transplantation
7%
Troponin
7%
Levosimendan
7%
Europe
7%
Chest Pain
7%
Myocarditis
7%
Percutaneous Coronary Intervention
6%
Coronary Artery Disease
6%
Heart Failure
6%
Survivors
6%
Medicine and Dentistry
Cardiogenic Shock
95%
Acute Coronary Syndrome
54%
Cardiovascular System
24%
Hospital Mortality
19%
Cardiology
17%
ST Elevation
16%
Elderly Patient
15%
Takotsubo Cardiomyopathy
15%
All Cause Mortality
15%
Risk Stratification
14%
ST Segment Elevation Myocardial Infarction
14%
Congestive Heart Failure
14%
Hazard Ratio
12%
Angiography
12%
Acute Decompensated Heart Failure
12%
Troponin T
12%
Biological Marker
11%
Frailty
11%
Pulmonary Artery Catheter
11%
Emergency Department
11%
Electrocardiogram
11%
Prevalence
11%
Organ Injury
11%
ST Segment
10%
Ischemic Heart Disease
10%
Growth Differentiation Factor 15
10%
Myocarditis
10%
Out of Hospital Cardiac Arrest
10%
Hemodynamic
9%
Cardiac Troponin
9%
Non ST Segment Elevation Myocardial Infarction
9%
Coronary Angiography
8%
Heart Transplantation
8%
Brain Natriuretic Peptide
8%
Epinephrine
7%
Catecholamine
7%
Amino Terminal Sequence
7%
Levosimendan
7%
Proportional Hazards Model
7%
Percutaneous Coronary Intervention
7%
Reperfusion Therapy
7%
Low Density Lipoprotein Cholesterol
7%
Drug Therapy
6%
Thorax Pain
6%
Noradrenalin
6%
Alanine Aminotransferase
6%
Inotropic Agent
6%
Prospective Cohort Study
6%
Cardiovascular Disease
6%
Geriatric Assessment
6%